About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 324 record(s)
Req # A-2023-000869
Adverse Drug Reactions (ADRs). Report numbers: 001032877, 001034437, 001034838, 001038896, 001042304, 001035863, 001038090, 001039491, 001042722.Organization: Health Canada
October 2023
Req # A-2023-000882
Adverse Drug Reaction (ADR). Report number: 001039714.Organization: Health Canada
October 2023
Req # A-2023-000898
Adverse Drug Reactions (ADRs) for BENADRYL. Report numbers: 001025260, 001050026. ADRs for REACTINE. Report numbers: 001020501, 001032539. ADRs for TYLENOL. Report numbers: 001015816, 001021323, 001021598, 001025911. ADR for BENZOCAINE. Report number: 001016740.Organization: Health Canada
October 2023
Req # A-2023-000899
Adverse Drug Reactions (ADRs) for ACETAMINOPHEN. Report numbers: 001029707, 001035137, 001037832.Organization: Health Canada
October 2023
Req # A-2023-000902
Adverse Drug Reactions (ADRs) for MOTRIN. Report numbers: 001048236, 001048837, 001049292, 001049949, 001049969, 001050122.Organization: Health Canada
October 2023
Req # A-2023-000904
Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001013761, 001015268, 001018555, 001022658, 001023661, 001023706, 001028874, 001031987, 001038200, 001039630.Organization: Health Canada
October 2023
Req # A-2023-000906
Adverse Drug Reactions (ADRs) for IBUPROFEN. Report numbers: 001043002, 001047381, 001049982.Organization: Health Canada
October 2023
Req # A-2021-00032
All documents regarding BLACK CUBE and/or Vivian Bercovici from 2016 to 12 30 2021. For the year 2021, I request only email correspondence sent or received by management, from the Assistant Deputy Ministers to Deputy Chiefs/associated Deputy Chiefs up to the the Chief of CSE.Organization: Communications Security Establishment Canada
October 2022
Req # A-2022-00005
All briefing notes, memos and reports held by the Chief and Associate Chief regarding the use of polygraphs from May 1 2022 to July 4, 2022Organization: Communications Security Establishment Canada
October 2022
Req # A-2022-00006
All reports, briefs, assessments or meeting notes developed between 5:00 am and 10:30 am EST on July 8 2022, mentioning or referencing disruptions to Rogers or Interac services across Canada.Organization: Communications Security Establishment Canada
October 2022